Arthritis clinical trials at UC Davis
2 research studies open to eligible people
Afabicin in The Treatment of Participants With Bone or Joint Infection Due to Staphylococcus
“Volunteer for research and contribute to discoveries that may improve health care for you, your family, and your community!”
open to eligible people ages 18 years and up
This is a randomized, active-controlled, open-label study to assess the safety, tolerability and efficacy of Afabicin in the treatment of participants with bone or joint infection due to Staphylococcus aureus [both methicillin-susceptible S. aureus (MSSA) and methicillin-resistant S. aureus (MRSA)] and/or coagulase-negative staphylococci (CoNS) and to compare it to standard of care (SOC).
Augusta, Georgia and other locations
Sustained Dynamic Compression Intramedullary Nail for Subtalar Arthrodesis
open to eligible people ages 18 years and up
The purpose of this study is to determine the clinical efficacy of a novel dynamic sustained compression intramedullary nail for subtalar (talocalcaneal) arthrodesis.
Sacramento, California
Our lead scientists for Arthritis research studies include Christopher Kreulen, MD, MS.